Relationship between skeletal muscle mass and prognosis in patients with liver cancer receiving targeted therapy: A meta-analysis

Figure 1 Flow chart of literature screening. SMI: Skeletal muscle index; HR: Hazard ratio; CI: Confidence interval.

Figure 2 Forest plots comparing overall survival of patients with liver cancer treated with targeted drugs between the two groups, low skeletal muscle index group vs non-low skeletal muscle index group. A: Forest plot of overall survival of two groups of patients with liver cancer; B: Subgroup analysis of ethnicity in two groups of patient with liver cancer; C: Subgroup analysis of targeted drug in two groups of patients with liver cancer. HR: Hazard ratio; CI: Confidence interval.

Figure 3 Funnel plot after applying a trim-and-fill method.

Figure 4 Sensitivity analysis of overall survival of two groups of patients with liver cancer. CI: Confidence interval.

Figure 5 Forest plot comparing overall survival of patients with liver cancer treated with targeted drugs between the two groups, non-low skeletal muscle index group vs low skeletal muscle index group. HR: Hazard ratio; CI: Confidence interval.

Figure 6 Sensitivity analysis of overall survival of two groups of patients with liver cancer. CI: Confidence interval.